HH-006 Chronic Hepatitis B Trial, Huahui Health
Summary
ClinicalTrials.gov registered the HH-006 clinical trial sponsored by Huahui Health, evaluating the safety and efficacy of an investigational treatment for chronic hepatitis B infection. The trial is now publicly listed with identifier NCT07519330, providing transparency on ongoing clinical research.
What changed
ClinicalTrials.gov published the registration for the HH-006 chronic hepatitis B trial sponsored by Huahui Health. The entry includes the NCT identifier, study design parameters, participant eligibility criteria, and investigator contact information.
Affected parties including clinical investigators, trial sponsors, and institutional review boards should reference this registry entry to verify trial status, recruitment information, and regulatory compliance documentation. Patients seeking enrollment should review eligibility criteria and contact study sites directly.
What to do next
- Monitor ClinicalTrials.gov for trial updates and results
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NLM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.